中国寄生虫学与寄生虫病杂志 ›› 1992, Vol. 10 ›› Issue (1): 14-17.

• • 上一篇    下一篇

抗蠕虫新药AH-85012遗传毒理的研究

邱则吟,王捷,谢婉,巫俊侠,苏永芳,吴幼瑜   

  1. 四川省医科院寄生虫病防治研究所
  • 收稿日期:2017-01-09 修回日期:2017-01-09 出版日期:1992-02-28 发布日期:2017-01-09

STUDY ON TOXICOLOGY OF A NEW ANTHELMINTIC “85012”

  • Received:2017-01-09 Revised:2017-01-09 Online:1992-02-28 Published:2017-01-09

摘要: 采用小鼠骨髓嗜多染细胞微核试验、染色体畸变试验、精子畸形试验及CHL细胞染色体畸变试验,对本所研制的N’-[4-(胡椒醛缩胺基)苯基]-N,N-二甲基乙脒代号为AH-85012进行体内及体外的诱变性研究,并进行大鼠生殖毒性研究,证明该化合物无致突变性和致畸性。

关键词: 微核, 染色体畸变, 致突变性, 致畸性

Abstract: "85012",a new anthelmintic containing amidine synthesized in our laboratory,was ex perimeatally effective against Nippostrongylus braziliensis an.d Ancylostoma caninum.In acute and subacute toxicity test,it was proved lowly toxic.There was no evidence that the drug induced any damages to main organs and tissues of animals.In order to evaluate its potential mutagenicity and teratogenicity,micronucleus test,bone marrow metaphase analysis,CHL cells chromosomal aberration assay,spermatic aberration test as well as teratogenicity test were performed.No mutagenic and teratogenic effects were observed.